Board Meeting Is Scheduled To Be Held On November 14, 2017.
Dear Sir(s), Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017 to, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017.... Paradise Papers leak: No violation by Fortis doctor, says IMA
Reports linked to the Paradise Papers have alleged that Dr Seth has prescribed stents of Biosensors International to his patients despite being a shareholder of the co
Rekha Jhunjhunwala ups shareholding in Fortis Healthcare
Rakesh and Rekha Jhunjhunwala, as per the latest September 2017 filings, have put more money in Fortis Healthcare, Prakash Industries and Lupin Limited. Fortis Healthcare received investments from Rekha Jhunjhunwala, when she had first picked up a 0.9% stake in the company for an estimated Rs 60 crores, through an open market transaction in August - a holding which has now jumped to 1.54%. Iron and steel company Prakash Industries had been in the news early August after SEBI added it to a list of shell companies, restricting its trading. But the restriction was later stayed and trading in the company resumed. Since then, Prakash Industries' share price has been trending up and got a boost today with news of Jhunjhunwala's increased investment in the stock. Pharma company Lupin Limited is another stock in which Jhunjhunwala's stake has increased, from 1.76% in June to 1.89% in September. Certificate Under Regulation 40(10) Of SEBI (LODR)Regulations, 2015 For The Half Year Ended September 30, 2017.
Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a Certificate received from M/s. Mukesh Agarwal & Co., Company Secretaries, for the half-year ended on September 30, 2017. Kindly acknowledge receipt of the same. Statement On Investor Complaints Under Regulation 13(3) For The Quarter Ended September 30, 2017.
Please find enclosed the Statement giving the number of investor complaints pending at the beginning of the quarter, those received during the quarter, disposed of during the quarter and those remaining unresolved at the end of the quarter ended September 30, 2017, as received from the Registrar and Transfer Agent, pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.... Shareholding for the Period Ended September 30, 2017
Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Compliance For The Month Ending September 30, 2017
This is to certify that in terms of Regulation 7(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the activities in relation to both physical and electronic share transfer facility are maintained at / by M/s. Karvy Computershare Private Limited, Hyderabad (registered with SEBI), the Registrar & Transfer Agent of the Company. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Outcome of AGM
It is hereby informed that Fortis Healthcare Limited ('the Company') held its 21st Annual General Meeting ('AGM') on September 26, 2017 at 12:00 Noon at the National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali, Punjab - 160062. With reference to the above, please find enclosed the following: 1.Proceedings of the AGM in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; and... Updates
This is with reference to the recent news item which appeared in Newspaper - The Economic Times dated September 14, 2017, captioned "Religare's Institutional Shareholders move court seeking ouster of Board'. In this regard, Religare Enterprises Limited ('REL') has given intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a copy of which is attached for your reference....